RxDoctor Payments Data

Richard Banks, MD

Family Medicine · Fairfield, OHNPI 1245289529

Payments from drug & device makers

$783in general payments, 2019–2025

Across 42 payments — averaging $18.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$125
  • Exact Sciences$119
  • AbbVie$84
  • Novo Nordisk$59
  • Imperative Care, Inc$51
  • Abbott$39
  • plus $305 from 16 others

What the payments were for

  • Food & beverage$783100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$783 in reported general payments places this provider in the 60th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$107,067
Medicare patients
306
Services billed
1,364

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide45$75,427
EliquisApixaban81$74,530
XareltoRivaroxaban60$63,329
OzempicSemaglutide45$60,738
JardianceEmpagliflozin40$43,052
JanuviaSitagliptin Phosphate20$32,603
MyrbetriqMirabegron38$27,117
FarxigaDapagliflozin Propanediol27$24,689
MounjaroTirzepatide12$18,380
TradjentaLinagliptin15$14,792
InvokanaCanagliflozin17$14,451
Lantus SolostarInsulin Glargine,hum.Rec.Anlog97$12,529
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$8,332
BelsomraSuvorexant12$7,007
Tresiba Flextouch U-100Insulin Degludec11$6,700

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$25$93,80857 claims
Johnson & JohnsonXarelto, Invokana$23$77,78077 claims
PfizerEliquis$36$74,53081 claims
Novo NordiskOzempic$59$60,73845 claims
Boehringer IngelheimJardiance, Tradjenta$11$57,84555 claims
MerckJanuvia, Belsomra$18$39,61032 claims
Astellas Pharma US IncMyrbetriq$19$27,11738 claims
AstraZenecaFarxiga$14$24,68927 claims
GSKTrelegy Ellipta$17$8,33214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Fairfield

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →